Hi folks,
I have RNAseq data with tumor samples without matched normal samples. Unfortunately, I don't have any DNA or RNA samples, or DNA-seq data. My purpose is to check some cancer-specific mutations, very well-known mutations. Those mutations cannot be germline mutations. Actually, no matter if they are germline or somatic, I just want to know if those samples have the mutations. I just want to make sure that the mutations are not filtered out.
Question is,
- Is it generally OK if I can understand the output of somatic callers is a subset of the output of germline callers, in case of tumor-only sample.
- If so, can I use germline variant callers not to lose my mutation? When I look around, DeepVariant-RNAseq seems to be the best practice for RNAseq germline variant calling.
- I don't know if the germline callers filter-out variants based on AF with high dispersion from 0.5 or 1.
My study is not for clinical purpose, and all the findings will be validated with wet experiments with cell lines. but I want to make sure how confident my data is for publication.
Thanks
In general the output of somatic callers is not a subset of the output from germinline callers. Germline callers try to call variants that are present at frequencies that are compatible with them being hetrozygous (i.e. carried by approximately 50% of reads) or homozygous (carried by nearly all reads). Somatic variant callers try to call variants whose frequencies are NOT compatible with being hetrozygous or homozygous.
did you check out this?
https://gatk.broadinstitute.org/hc/en-us/articles/360035531192-RNAseq-short-variant-discovery-SNPs-Indels
i believe this is what you are looking for.